Professional

Innovation in the round – the HTA’s cells and tissues partner discussion

Submitted by Roshana on

In our last blog, the HTA outlined how we and our stakeholders have a clear role to play in achieving the governments’ Life Sciences Vision, together delivering a progressive UK regulatory offer that unlocks innovation while safeguarding patients and ensuring public confidence.  To do this, we need to constructively challenge our regulatory model and tools, looking at how we&nbs

HTA announces licence fees for 2022/23

Submitted by Roshana on

Today the Human Tissue Authority (HTA) has published licence fee levels for the 2022/23 business year. 

 

Having held license fees at 2020/21 levels for the current business year the HTA Board have approved an increase of 2% on the current fee levels.  This increase will take effect from 1 April 2022 on the previous year’s fees. Read the full sector breakdowns.